UBS AM’s Cyclerion Therapeutics CYCN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-507
| Closed | -$11.3K | – | 2708 |
|
|
2022
Q1 | $11.3K | Hold |
507
| – | – | ﹤0.01% | 2776 |
|
|
2021
Q4 | $17.5K | Hold |
507
| – | – | ﹤0.01% | 2836 |
|
|
2021
Q3 | $31.2K | Hold |
507
| – | – | ﹤0.01% | 2737 |
|
|
2021
Q2 | $39.6K | Hold |
507
| – | – | ﹤0.01% | 2743 |
|
|
2021
Q1 | $28.3K | Hold |
507
| – | – | ﹤0.01% | 2597 |
|
|
2020
Q4 | $31.1K | Sell |
507
-724
| -59% | -$44.3K | ﹤0.01% | 2542 |
|
|
2020
Q3 | $150K | Hold |
1,231
| – | – | ﹤0.01% | 2437 |
|
|
2020
Q2 | $145K | Sell |
1,231
-2,217
| -64% | -$262K | ﹤0.01% | 2429 |
|
|
2020
Q1 | $183K | Buy |
3,448
+1,311
| +61% | +$69.5K | ﹤0.01% | 2297 |
|
|
2019
Q4 | $116K | Sell |
2,137
-49,882
| -96% | -$2.71M | ﹤0.01% | 2507 |
|
|
2019
Q3 | $12.6M | Buy |
52,019
+11,741
| +29% | +$2.85M | 0.01% | 882 |
|
|
2019
Q2 | $9.22M | Buy |
+40,278
| New | +$9.22M | 0.01% | 989 |
|